No abstract available
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Antineoplastic Agents, Immunological / therapeutic use
-
Brain Neoplasms / prevention & control
-
Brain Neoplasms / secondary*
-
Disease-Free Survival
-
Extremities
-
Female
-
Humans
-
Ipilimumab / therapeutic use
-
Male
-
Melanoma / drug therapy
-
Melanoma / pathology*
-
Melanoma / secondary*
-
Population Surveillance*
-
Risk Factors
-
Sex Factors
-
Skin Neoplasms / drug therapy
-
Skin Neoplasms / pathology*
-
Skin Ulcer / etiology
-
Survival Rate
Substances
-
Antineoplastic Agents, Immunological
-
Ipilimumab